Document is current

Any future updates will be listed below

Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment

Crossref DOI link: https://doi.org/10.1186/s40425-017-0258-x

Published Online: 2017-07-18

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark